Table 1 Baseline characteristics of subjects.

From: Nonarteritic anterior ischemic optic neuropathy and incidence of Parkinson’s disease based on a nationwide population based study

 

Total (N = 263,760)

NAION (N = 43,960)

Controls (N = 219,800)

p value

Age, years

61.7 ± 10.9

61.7 ± 10.9

61.7 ± 10.9

> 0.999

≥ 65 years

110,838 (42.0)

18,473 (42.0)

92,365 (42.0)

> 0.999

Sex, male, n (%)

116,718 (44.3)

19,453 (44.3)

97,265 (44.3)

> 0.999

Follow-up duration, years

3.7 ± 2.0

3.7 ± 2.0

3.7 ± 2.0

0.551

Income, lower 20%

55,986 (21.2)

8,507 (19.4)

47,479 (21.6)

< 0.001

Obesity, n (%)

95,925 (36.4)

15,183 (34.5)

80,742 (36.7)

< 0.001

Current Smoker, n (%)

38,924 (14.8)

5,331 (12.1)

33,593 (15.3)

< 0.001

Drinking, n (%)

89,601 (34.0)

14,280 (32.5)

75,321 (34.3)

< 0.001

Regular exercise, n (%)

57,005 (21.6)

9,964 (22.7)

47,041 (21.4)

< 0.001

DM, n (%)

45,735 (17.3)

9,199 (20.9)

36,536 (16.6)

< 0.001

HTN, n (%)

120,374 (45.6)

20,872 (47.5)

99,502 (45.3)

< 0.001

Dyslipidemia, n (%)

99,374 (37.7)

18,337 (41.7)

81,037 (36.9)

< 0.001

CKD, n (%)

20,251 (7.7)

3,587 (8.2)

16,664 (7.6)

< 0.001

Peptic ulcer, n (%)

24,017 (9.1)

4,565 (10.4)

19,452 (8.9)

< 0.001

  1. Data are presented as mean ± standard deviation.
  2. NAION nonarteritic anterior ischemic optic neuropathy, DM diabetes mellitus, HTN hypertension, CKD chronic kidney disease.